Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion type Assertion NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_head.
- NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion description "[Reduced GSNO levels have been implicated in several respiratory diseases, and inhibition of GSNO reductase, (GSNOR) the primary enzyme that metabolizes GSNO, represents a novel approach to treating inflammatory lung diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_provenance.
- NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion evidence source_evidence_literature NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_provenance.
- NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion SIO_000772 23285246 NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_provenance.
- NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion wasDerivedFrom befree-20140225 NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_provenance.
- NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_assertion wasGeneratedBy ECO_0000203 NP788780.RA7B2tP4z_oNoyS7BWNXq9KlJAu3lrUEK0aLh8SylNfbE130_provenance.